Bright Minds Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 1, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	1,163	598	7	8	28	107
Market Cap Growth	257.34%	9016.50%	-19.09%	-71.17%	-73.71%	-
Enterprise Value	1,074	547	0	0	19	85
Last Close Price	118.81	84.39	1.47	2.15	8.50	45.20
PB Ratio	13.02	7.29	1.19	1.23	2.67	5.51
P/TBV Ratio	13.02	7.29	1.19	1.23	2.67	5.52
Debt / Equity Ratio	0.00	0.00	0.02	0.01	0.01	-
Net Debt / Equity Ratio	-1.00	-1.01	-1.01	-1.01	-1.09	-1.02
Quick Ratio	56.59	35.68	10.92	24.16	8.00	31.12
Current Ratio	57.37	36.10	11.32	24.26	8.11	31.38
Return on Equity (ROE)	-26.98%	-27.93%	-46.18%	-86.02%	-99.95%	-85.94%
Return on Assets (ROA)	-15.72%	-18.80%	-25.28%	-47.45%	-57.32%	-51.52%
Return on Capital Employed (ROCE)	-21.00%	-16.60%	-47.10%	-109.10%	-138.80%	-44.40%
Earnings Yield	-1.71%	-2.04%	-42.70%	-90.90%	-53.20%	-8.09%
Buyback Yield / Dilution	-48.78%	-59.58%	-15.87%	-50.58%	-37.64%	-148.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.